热门资讯> 正文
Tectontic Therapy任命Daniel Lochner为首席财务官
2024-06-04 04:24
- Tectonic Therapeutic (NASDAQ:AVRO) on Monday announced the appointment of Daniel Lochner as Chief Financial Officer.
- Prior to joining Tectonic, Lochner served as Chief Business Officer and CFO of Viatris' Eye Care Division following Viatris’ acquisition of Oyster Point Pharma, where he had previously served as CFO and Chief Business Officer.
- Earlier in January, Tectonic entered into a definitive agreement to merge with AVROBIO.
- Source: Press Release
More on AVROBIO
- Seeking Alpha’s Quant Rating on AVROBIO
- Historical earnings data for AVROBIO
- Financial information for AVROBIO
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
